Randall Michael Giuffre Dia Medica Therapeutics Inc. (DMAC) insider trading activity
Randall Michael Giuffre is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 364,551 shares of DMAC, which is worth approximately $1.6 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 19,196 shares (Voting Common Shares, no par value per share) at a price of $2.8 per share, resulting in proceeds of $53,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
365K
0%
3M change
5.56%
12M change
Total Value Held
$1.6 Million
Randall Michael Giuffre Transaction History
RMG
Randall Michael Giuffre
Director
Minneapolis, MN